We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

CRISPR and Genome Editing – News and Features

News

RheoGene Grants Ichor License to Develop a Regulated Gene Therapy

Ichor has granted an option for RheoGene to license Ichor’s TriGrid™ Delivery System to develop proprietary therapeutics.
News

Significant Technological Challenges Remain for the Development of RNA-Based Therapeutics

In this Decision Resources report three RNA-based technologies are described.
News

Researchers Develop Remote Control Gene Expression Tool

This versatile package can carry bits of RNA that stop the cell from expressing one of its own genes.
News

Sigma-Aldrich Expands shRNA Libraries of the RNAi Consortium

The collection now carries 65,000 shRNA vector constructs that target 9,500 human genes and 3,400 mouse genes.
News

Lentigen and ZGene Enter License Agreement for Selected ZGene Intellectual Property

Lentigen gains exclusive, world-wide license to multisubstrate kinase gene technology.
News

Genzyme Strengthens Its Gene Therapy Program

Genzyme bought extensive gene therapy assets from US company Avigen in December.
News

Sangamo Announces Expansion of Research Collaboration Agreement with Pfizer

Sangamo will use its ZFP technology to develop cell lines for enhanced protein production.
News

Dharmacon and MIT Settle RNAi License Dispute

MIT has dismissed all of its legal claims against Dharmacon and its parent company Fisher Scientific International Inc.
News

Gene Therapy for Muscular Dystrophy Fixes Frail Muscle Cells in Animal Model

Researchers used gene therapy to introduce a healthy copy of the gene dystrophin into mice with a condition that mimics muscular dystrophy.
News

Researchers Demonstrate new way to Switch Therapeutic Genes 'On' and 'Off'

Researchers have created a genetic switch system that is turned on in the presence of the antibiotic tetracycline.
Advertisement